… In the same study administration of a novel CSF1R inhibitor attenuated a disease-associated
microglial phenotype and blocked the axonal damage and neurological impairments in an …

… This progression parallels the cognitive decline observed predominantly in older patients.
AD is characterized by the presence of amyloid beta (Aβ) plaques and neurofibrillary tangles (…

Trace amines and their biochemistry: Trace amines represent endogenous monoamines
present in very low concentration (usually nM) in the brain in comparison to classical …

… Prevalence and clinical aspects of mild cognitive impairment in Parkinson's disease: A
meta-analysis [J]. Mov Disord, 2020, 35(1): 45-54 [17] Hong-Tao M, Zhan-Ning LI, Jun-Hong HE, …

… for cell therapy for Parkinson’s disease, as well as the necessary safety standards
needed for using iPSC transplantation to slow or halt the progression of Parkinson’s disease. …

… Parkinson's disease ⁃ associated mutant VPS35 causes mitochondrial dysfunction by
recycling DLP1 complexes[J]. Nat Med, 2016, 22:54⁃63. Zhang S, Wang XJ, Tian LP, Pan J, Lu …

… , including vascular dementia, Parkinson’s disease associated with dementia, frontal dementia…
Figure 2 Neurons of the locus coeruleus of a case of Parkinson’s disease associated with …

… The only known genetic neurological disease associated with tubulin glutamylation is …
disease-associated proteins, such as tau in Alzheimer’s disease and alpha-synuclein in Parkinson’…

… carried by these vesicles were able to identify people with sub-clinical cognitive decline and
predict longitudinal changes in cognitive performance (Kapogiannis et al., 2019; Eren et al., …

… Objective To investigate the effect of different levels of physical activity on the risk of Parkinson's
… Reduced risk of Parkinson's disease associated with lower body mass index and heavy …